TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

News

Brief news reports on Tuberculosis

Battle royale: How bacteria fight antibiotics and up the ante in chemical warfare

Inadequate development of new antibiotics and rising rates of resistance by bacteria to existing antimicrobials are dual forces pushing the world ever closer to a post-antibiotic era.

Read More →

Vitamin D supplementation may not lower risk of TB infection, finds NEJM study

Researchers have found in a new study that vitamin D supplementation did not result in a lower risk of TB infection or TB disease. The study has been published in the New England Journal of Medicine.

Read More →

New cell profiling method could speed TB drug discovery

Technology combines rapid imaging and machine learning to uncover patterns in how antibacterials kill; can be applied to many pathogens

Read More →

Global TB Caucus partner newsletter

The Global TB Caucus released a newsletter listing the key activities and outcomes of the Caucus for the first half of 2020.

Read More →

India sends $1 million worth of anti-tuberculosis medicine to North Korea

The Indian government sent $1 million worth of anti-tuberculosis medicine to North Korea per a request from the World Health Organization (WHO), according to a press release issued by the Indian embassy in Pyongyang on Wednesday (July 22).

Read More →

Mylan secures DCGI approval in India for pretomanid, a treatment for highly drug-resistant forms of TB

Pretomanid is only the third new anti-tuberculosis (TB) drug developed specifically for drug-resistant forms of the disease to be approved in more than 40 years

Approval comes as a result of Mylan’s global collaboration with non-profit drug development partner TB Alliance

Read More →

Call for expressions of interest: Systematic reviews on dose optimization of the first-line TB medicines

22 July 2020, Geneva | The World Health Organization (WHO) Global Tuberculosis Programme has initiated a process for the collection and assessment of evidence on whether the dosing of rifampicin, isoniazid, ethambutol and pyrazinamide requires further optimization to safely improve treatment success and reduce unfavourable treatment outcomes in TB patients on first-line treatment regimens.

Read More →

Activating a human rights-based TB response

A technical brief for policymakers and program implementers - a joint effort of the Global Coalition of TB Activists, the Stop TB Partnership and the Northwestern Pritzker School of Law.

Read More →

Indonesia steps up battle against tuberculosis amid COVID-19 pandemic

JAKARTA, July 21 -- Indonesian President Joko Widodo on Tuesday ordered authorities to aggressively trace those infected by mycobacterium tuberculosis and the COVID-19 virus at the same time in a bid to bring down the number of cases.

Read More →

New artificial intelligence resource center for TB diagnosis

20 July 2020, Geneva, Switzerland- The Stop TB Partnership and the Foundation for Innovative New Diagnostics (FIND) today launched an online resource center of computer-aided detection (CAD) products for the diagnosis of tuberculosis (TB): www.ai4hlth.org.

Read More →

Page 180 of 895 · Total posts: 10

←First 179 180 181 Last→